New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F15%3A00084307" target="_blank" >RIV/00216224:14110/15:00084307 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11110/15:10312496 RIV/00216208:11120/15:43910910 RIV/65269705:_____/15:00063350 RIV/00023698:_____/15:#0000190 RIV/00064165:_____/15:10312496
Výsledek na webu
<a href="http://dx.doi.org/10.4149/neo_2015_062" target="_blank" >http://dx.doi.org/10.4149/neo_2015_062</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2015_062" target="_blank" >10.4149/neo_2015_062</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers
Popis výsledku v původním jazyce
Early diagnosis is a prerequisite of the more successful treatment of cancer. In gynaecological cancers, such as ovarian, endometrial and cervical cancers, the recent efforts are aimed at finding novel diagnostic biomarkers to help reduce the worldwide health burden associated with these cancers. In this review, we focus on the recent research progress in circulating, particularly cell-free microRNAs expression achieved in ovarian, endometrial and cervical cancers showing an opportunity to find novel diagnostic biomarkers for these malignant diseases. With the onset of microRNAs investigations showing their diagnostic potential in many diseases, their role in gynaecological cancers has been examined as well. However, similarly as in many other diseases, the vast majority of research on microRNAs expression has been dealing with tissue samples and cell lines.
Název v anglickém jazyce
New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers
Popis výsledku anglicky
Early diagnosis is a prerequisite of the more successful treatment of cancer. In gynaecological cancers, such as ovarian, endometrial and cervical cancers, the recent efforts are aimed at finding novel diagnostic biomarkers to help reduce the worldwide health burden associated with these cancers. In this review, we focus on the recent research progress in circulating, particularly cell-free microRNAs expression achieved in ovarian, endometrial and cervical cancers showing an opportunity to find novel diagnostic biomarkers for these malignant diseases. With the onset of microRNAs investigations showing their diagnostic potential in many diseases, their role in gynaecological cancers has been examined as well. However, similarly as in many other diseases, the vast majority of research on microRNAs expression has been dealing with tissue samples and cell lines.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FK - Gynekologie a porodnictví
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Neoplasma
ISSN
0028-2685
e-ISSN
—
Svazek periodika
62
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
SK - Slovenská republika
Počet stran výsledku
12
Strana od-do
509-520
Kód UT WoS článku
000362862500001
EID výsledku v databázi Scopus
—